Articles Referencing MACK

Sanofi/MACK Candidate Progresses - Analyst Blog

3/20/2013, 4:29 pm from Zacks.com in Investing, Business, Stocks

Merrimack Pharmaceuticals, Inc. ( MACK ) recently announced that it has completed the enrollment process for a phase II trial on its oncology candidate, MM-121. The phase II trial... Read >>

After Hours Most Active for Nov 16, 2012 : SFD, QQQ, WIN, TSN, MSFT, TSS, BAC, MYL, ZGNX, WM, MACK, MMC

11/16/2012, 4:44 pm from NASDAQ.com News in News Headlines, After Hours Most Active

The NASDAQ 100 After Hours Indicator is up 4.33 to 2,538.49. The total After hours volume is currently 37,965,737 shares traded. The following are the most active stocks for the after... Read >>

Street research for Merrimack Pharmaceuticals expected on May 8

5/3/2012, 7:00 am from Renaissance Capital in Investing, IPOs

Street research for Merrimack Pharmaceuticals, which uses its Network Biology system to discover and develop cancer treatments, is expected to be released on 5/8/12. On 3/28/12, the... Read >>

Merrimack prices IPO at $7, raising $100 million in proceeds

3/28/2012, 5:52 pm from Renaissance Capital in Investing, IPOs

Merrimack Pharmaceuticals, which uses its Network Biology system to discover and develop cancer treatments, raised $100 million by offering 14.3 million shares at $7 on Wednesday ... Read >>

Merrimack Pharmaceuticals sets new terms, now seeking $100 million

3/26/2012, 9:14 am from Renaissance Capital in Investing, IPOs

Merrimack Pharmaceuticals, which postponed its IPO in February, announced new terms on Monday. The Cambridge, MA-based company now plans to raise $100 million (down from $150 million) ... Read >>

10 US IPOs planned for the week of Mar 26

3/26/2012, 8:00 am from Renaissance Capital in Investing, IPOs

The following IPOs are expected to price this week : Annie's (BNNY), which is leading organic and natural packaged food company known for its mac-n-cheese, plans... Read >>